Stagnant US Mammography Rates and the Influence of COVID-19
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Mammography rates had stagnated over recent years in the US, and then came COVID-19. The pandemic put life on hold for many people, including their receipt of preventive care such as mammography screenings.The aftermath of the pandemic on mammography rates isn’t clear yet because, as the American Cancer Society (ACS) notes in its recent 2022 cancer projections report, quantifying “secondary consequences of the pandemic at the population level will take several years because of the lag in dissemination of population-based surveillance data.” Nevertheless, some studies already offer insight into the pandemic’s effect.
JAMA , article en libre accès, 2021